SAN FRANCISCO, July 23, 2020 /PRNewswire/ -- Kindred
Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company
focused on saving and improving the lives of pets, will release its
second quarter 2020 financial results on August 5, 2020, after the market close. The
Company will host a conference call at 4:30
p.m. Eastern time/1:30 p.m. Pacific
time that day.
Access the call by dialing toll-free (888) 771-4371 from the
U.S. or (847) 585-4405 internationally, and using conference ID
49852246.
The call will also be webcast live here, with a replay available
at that link for 30 days.
About Kindred Biosciences
Kindred Biosciences is a
biopharmaceutical company developing innovative biologics focused
on saving and improving the lives of pets. Its mission is to bring
to pets the same kinds of safe and effective medicines that human
family members enjoy. The company's strategy is to identify targets
that have already demonstrated safety and efficacy in humans and to
develop therapeutics based on these validated targets for dogs and
cats. KindredBio has a deep pipeline of novel biologics in
development across many therapeutic classes, alongside
state-of-the-art biologics manufacturing capabilities and a broad
intellectual property portfolio.
For more information, visit: www.kindredbio.com
Contact
Katja Buhrer
katja.buhrer@kindredbio.com
(917) 969-3438
View original content to download
multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-announce-second-quarter-2020-financial-results-301098421.html
SOURCE Kindred Biosciences, Inc.